Perimeter Capital Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Perimeter Capital Partners’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-26,427	Closed	-$230K	–	36
2014 Q3	$230K	Sell	26,427 -123,632	-82%	-$1.12M	0.39%	73
2014 Q2	$1.64M	Sell	150,059 -6,396	-4%	-$57K	0.84%	24
2014 Q1	$1.4M	Buy	+156,455	New	+$1.44M	0.7%	67

Other funds holding SUPN

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Ardsley Advisory Partners Stamford, Connecticut $921M AUM 207.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mutual of America Capital Management New York $8.8B AUM 29.06% 1-Year Est. Return